Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.54B |
| 2 |
Apple
AAPL
|
+$5.8B |
| 3 |
Amazon
AMZN
|
+$3.28B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.19B |
| 5 |
Mastercard
MA
|
+$3.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snap
SNAP
|
+$380M |
| 2 |
Twilio
TWLO
|
+$357M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$329M |
| 4 |
AVLR
Avalara, Inc.
AVLR
|
+$150M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.7% |
| 2 | Healthcare | 21.23% |
| 3 | Financials | 11.2% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
451
DELISTED
PotlatchDeltic
PCH
| $66.6M | 0.02% |
1,622,816
+515,554
| +47% | +$23.7M |
|
|
DICE
452
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $66.3M | 0.02% |
3,271,296
+1,561,976
| +91% | +$28.5M |
|
453
Criteo
CRTO
$1.14B
| $66.3M | 0.02% |
2,450,332
+1,184,149
| +94% | +$31M |
|
454
Mondelez International
MDLZ
$83.4B
| $65.8M | 0.02% |
1,200,972
+544,685
| +83% | +$33.8M |
|
|
EGRX
455
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $65.5M | 0.02% |
2,479,558
+1,042,244
| +73% | +$38.2M |
|
456
UBS Group
UBS
$170B
| $65.3M | 0.02% |
4,438,028
+2,147,710
| +94% | +$34.4M |
|
457
First Horizon
FHN
$12.2B
| $64.9M | 0.02% |
2,833,652
+1,232,443
| +77% | +$28M |
|
|
HEES
458
DELISTED
H&E Equipment Services
HEES
| $64.7M | 0.02% |
2,283,110
+1,127,366
| +98% | +$35.5M |
|
459
Phillips Edison & Co
PECO
$5.5B
| $64.7M | 0.02% |
2,304,990
+519,414
| +29% | +$17.1M |
|
460
Vistra
VST
$48.2B
| $64.6M | 0.02% |
3,077,044
+1,572,992
| +105% | +$38.1M |
|
461
Portillo's
PTLO
$345M
| $64.2M | 0.02% |
3,260,842
+2,159,090
| +196% | +$47.5M |
|
462
FLEX LNG
FLNG
$1.69B
| $64.1M | 0.02% |
2,015,166
+475,893
| +31% | +$15.1M |
|
|
CLVT.PRA
463
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $63.9M | 0.02% |
1,507,554
+906,577
| +151% | +$48.2M |
|
464
Fate Therapeutics
FATE
$275M
| $63.9M | 0.02% |
2,849,452
+1,413,939
| +98% | +$40.9M |
|
465
Upwork
UPWK
$1.18B
| $63M | 0.02% |
4,625,736
+2,315,525
| +100% | +$43.5M |
|
466
Ambarella
AMBA
$3.04B
| $62.6M | 0.02% |
1,114,668
+542,747
| +95% | +$40.2M |
|
467
Alcon
ALC
$34B
| $62.3M | 0.02% |
1,057,182
+531,295
| +101% | +$36.9M |
|
468
COPT Defense Properties
CDP
$4.32B
| $61.4M | 0.02% |
2,643,454
+1,092,463
| +70% | +$28.6M |
|
469
Collegium Pharmaceutical
COLL
$1.18B
| $61.4M | 0.02% |
3,831,996
+1,622,993
| +73% | +$28.6M |
|
470
SBA Communications
SBAC
$19.8B
| $60.9M | 0.02% |
213,916
+104,636
| +96% | +$34M |
|
471
International Flavors & Fragrances
IFF
$20.3B
| $60.9M | 0.02% |
670,414
-59,380
| -8% | -$6.8M |
|
|
CNH
472
CNH Industrial
CNH
$13.3B
| $60.7M | 0.02% |
5,334,426
+1,642,290
| +44% | +$19.8M |
|
473
Moderna
MRNA
$21.6B
| $60.4M | 0.02% |
510,688
+232,552
| +84% | +$35.3M |
|
474
Sea Limited
SE
$66.4B
| $60.2M | 0.02% |
1,074,186
+171,108
| +19% | +$11.9M |
|
|
WBX
475
Wallbox
WBX
$76.7M
| $60.2M | 0.02% |
381,670
+260,408
| +215% | +$46.4M |
|
Similar funds
Janus Henderson Group's Q3 2022 Portfolio in Review
As of Q3 2022, Janus Henderson Group held 2,740 positions worth $267B, up 84% from $145B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group deployed $142B of net new capital in Q3 2022, opening 150 new positions and adding to 2,084 existing holdings. Its largest new stake was Schwab US Large- Cap ETF: 22,942,620 shares worth $324M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Snap, an estimated $380M trimmed.
- Janus Henderson Group's largest Q3 2022 buy was Schwab US Large- Cap ETF: 22,942,620 shares worth $324M.
- Janus Henderson Group added most to Microsoft in Q3 2022, an estimated $8.54B increase.
- Janus Henderson Group's biggest Q3 2022 reduction was Snap, cutting an estimated $380M.
- Janus Henderson Group fully exited Alibaba in Q3 2022, selling an estimated $65.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $267B portfolio in Q3 2022.
- Janus Henderson Group opened 150 new positions and closed 205 in Q3 2022.
- Janus Henderson Group's portfolio value rose 84% quarter-over-quarter to $267B.
Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.